IDiyas

For the Inventor, By the Inventor

Whitehouse Station, NJ, United States of America

Daniel Richard Sidler

USPTO Granted Patents = 12

Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 83(Granted Patents)


Location History:

  • Mansfield, PA (US) (1997 - 2001)
  • Whitehouse Station, NJ (US) (1998 - 2009)

Company Filing History:

goldMedal12 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1997-2009

Loading Chart...
12 patents (USPTO):Explore Patents
1. RE40794 - Crystalline forms of carbapenem antibiotics and methods of preparation (2009-06-22),
2. 7473696 - CCR-2 antagonist salt (2009-01-06),
3. 7145002 - Crystalline forms of carbapenem antibiotics and methods of preparation (2006-12-05),
4. 7022841 - Process for making carbapenem compounds (2006-04-04),
5. 6372911 - Process for preparing &bgr;-hydroxycarbamates and their conversion to oxazolidinones (2002-04-16),
6. 6320052 - Process for the preparation of leukotriene antagonists (2001-11-20),
7. 6320049 - Alpha 1a adrenergic receptor antagonists (2001-11-20),
8. 6207444 - Enzymatic process of making alpha 1a adrenergic receptor antagonists using protease (2001-03-27),
9. 6127545 - Process for making 2-aryl-3-aryl-5-halo pyridines useful as COX-2 (2000-10-03),
10. 5952323 - Carbapenem antibiotic (1999-09-14),
11. 5786472 - Process for making dihydropyrimidinones (1998-07-28),
12. 5614632 - Process for the preparation of leukotriene anatgonists (1997-03-25),

As an assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can certainly help with that. Here is an article on inventor Daniel Richard Sidler:

Title: Unveiling the Innovations of Daniel Richard Sidler

Introduction:

Daniel Richard Sidler, a distinguished inventor hailing from Whitehouse Station, NJ (US), has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 12 patents, Sidler is known for his groundbreaking work in developing new crystalline forms of carbapenem antibiotics and CCR-2 antagonist salts.

Latest Patents:

Sidler's latest patents include a process for preparing a crystalline, carbapenem monosodium salt of formula IIa, which involves a meticulous procedure of crystallization under specific conditions. Additionally, he has also patented an efficient synthesis for the preparation of a CCR-2 antagonist salt, known for its superior properties and crystalline structure.

Career Highlights:

Daniel Richard Sidler is a key figure at Merck & Co., Inc., a renowned pharmaceutical company where he has brought his innovative ideas to life. His tenure at Merck has been marked by numerous successful projects and patents that have revolutionized the pharmaceutical industry.

Collaborations:

In his collaborative efforts, Sidler has had the privilege of working with esteemed colleagues such as John M Williams and Robert D Larsen. Together, they have synergized their expertise to drive forward cutting-edge research and development initiatives in the pharmaceutical domain.

Conclusion:

In conclusion, Daniel Richard Sidler stands as a beacon of innovation in the realm of pharmaceutical inventions. His relentless pursuit of excellence and his ability to translate ideas into tangible patents have cemented his legacy as a pioneering inventor in the field. We look forward to witnessing more of his ingenious creations in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…